A Study to Learn About the Study Medicine - Precedex in Children From Japan.

Pfizer

Status: Completed

Conditions: Sedation

Treatments: Drug: Dexmedetomidine Hydrochloride

Study type: Observational

Funder types: Industry

Identifiers

NCT06085573

C0801044

NCT06085573 (Registry Identifier)

Details and patient eligibility

About

The purpose of this study is to look at the safety of Precedex when it was used to calm children at procedures or tests under actual medical practice in Japan.

This study is seeking for children who are 1 month to less than 18 years old.

The patients are planned to be looked over:

• From the time of patient check before receiving Precedex
• To 1 hour after the completion or stop of using Precedex.

Enrollment: 111 patients

Sex: All

Ages: 1 month to 17 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pediatric patients (1 month to < 18 years old) administered Precedex for "sedation of non-intubated pediatric patients for non-invasive procedures and tests"

Exclusion criteria

• No exclusion criteria is set out in this study.

Trial design

111 participants in 1 patient group

Dexmedetomidine Hydrochloride

Description:

Pediatric patients (1 month to \< 18 years old) administered Precedex (Dexmedetomidine Hydrochloride) for "sedation of non-intubated pediatric patients for non-invasive procedures and tests"

Treatment:

Drug: Dexmedetomidine Hydrochloride